(Q70134762)
Statements
Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients (English)
E Bork
M Hansen
P Dombernowsky
S W Hansen
A G Pedersen
scientific article published on 01 April 1986